21 March 2024 in Jornal de Pediatria
Age at menarche (MA) is a proxy for biological maturation and a parameter of socioeconomic changes. Worldwide, anticipation of menarche is associated with nutritional transition and excess weight. The objective of this study was to evaluate the MA in Amazonian students and its association with nutritional status, ethnicity, and socioeconomic level. Cross-sectional study with 1,017 students aged 6 to 17 living in the city of Manaus, Brazil. MA was analyzed by status quo and recall; its association with body mass index (BMI), race, socioeconomic status, and adult height was examined. 559 (51.9%) participants had already experienced menarche. In 91.7%, menarche occurred between 10 and 14 years of age; the mean age at the onset of menarche was 11.9 years. Overweight (11.6 years) and obese (11.4 years) participants reached menarche earlier than those with normal weight (12 years) and lean (12.7 years) participants. The associations between MA and nutritional status showed that overweight and obesity are risk factors for the early occurrence of menarche. MA was not associated with socioeconomic status/parental education or race. However, excess weight was associated with earlier MA in all races and social classes. The adult height was slightly lower in girls with menarche before 12 years old (157.9 vs 159.4 cm). Regardless of socioeconomic level or ethnicity, excess weight was associated with earlier menarche in Amazonian students.
1 March 2026 in Endocrine Connections
The childhood and adolescent obesity epidemic remains one of the most important and challenging health issues of the 21st century. Excess body weight affects the immediate health of children and adolescents, being associated with a higher and earlier risk of several non-communicable diseases (NCDs), such as type 2 diabetes and cardiovascular diseases, in addition to adverse psychosocial consequences and impacts on pubertal timing. Evidence dating back to the past century points to a secular trend of earlier puberty in boys and girls in various parts of the world, and this earlier onset has been attributed, at least in part, to obesity, especially in girls. In boys, this relationship is not as linear. Moreover, despite some contradictory results, most recent evidence points to earlier puberty also being associated with an excess of body weight in boys. Several mechanisms have been suggested to explain this possible relationship between puberty onset and obesity. However, the most promising link in this connection is leptin and its interaction with the kisspeptin system, in addition to an important contribution from insulin, which is frequently increased in obesity. The gut microbiota is implicated in the pathophysiology of obesity, which, in turn, is commonly associated with insulin resistance and the development of central precocious puberty, particularly in females. This review summarizes current knowledge on the relationship between obesity and the onset and progression of puberty in both sexes, as well as the pathways potentially involved in the pathophysiology of this association.
1 January 2026 in Archives of Endocrinology and Metabolism
Objective: This study evaluated the QoL of Brazilian adult patients with childhood-onset growth hormone deficiency GHD (CO-GHD), comparing those who continued GH replacement therapy (GHRT) after transition to adulthood with those who discontinued treatment and with healthy subjects. Subjects and methods: In this cross-sectional study, quality of life (QoL) was assessed using the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) questionnaire in 61 Brazilian adults aged 18-50 years. The sample included 31 patients with CO-GHD confirmed during the transition period, who continued or discontinued GHRT, and 30 matched controls. Results: GHD patients had poorer QoL, as indicated by higher QoLAGHDA scores than controls (median 8 [IQR 5-14] vs 4 [IQR 2-8]; p < 0.01). Continued GHRT in adulthood did not impact QoL compared with discontinued GHRT (8 [IQR 6-16] vs. 9 [IQR 5-12], p = 0.33). Overall, women had lower QoL irrespective of GHD (9 [IQR 6-13] vs. 5 [IQR 2-8.5], p = 0.01, women and men, respectively). We found no association between QoL-AGHDA scores and education level (p = 0.51), short stature (p = 0.78), associated pituitary deficiencies (p = 0.34), or overweight/obesity (p = 0.16). Conclusion: GHD impairs quality of life in young adults; however, our cross-sectional cohort did not show significant improvements in quality of life associated with GH replacement therapy. A multidisciplinary approach combining individualized treatment and psychosocial interventions remains essential.